Medical News

RSS

Largest ever academic-industry research project to find new drugs for ASD

An international consortium of scientists, led by Roche, King's College London, and Autism Speaks, is collaborating on one of the largest ever academic-industry research projects to find new methods for the development of drugs for autism spectrum disorder.

From CSL Ltd 19 Mar 2012

IOB, Delcath to launch CHEMOSAT system for Spanish cancer patients

Delcath Systems, Inc. announced today that the Company has entered into an initial launch and training agreement for the Delcath Hepatic CHEMOSAT Delivery system with the Instituto Oncologico Baselga (IOB), Grupo Quiron—a private hospital located in Barcelona, Spain.

19 Mar 2012

Hive Health Media article cites several tips to improve skin's health

Hive Health Media has recently published an article that presents several tips for those individuals who are seeking anti-aging solutions. As a cultural movement, as well as a healthcare trend, anti-aging has become a popular activity among many generations.

19 Mar 2012

Amphar, ETView Medical to distribute VivaSight airway devices

ETView Medical Ltd. announced today that it has entered into a distribution agreement with Amphar b.v. (Amphar). The agreement enables Amphar to market ETView's VivaSight platform, combining an airway ventilation tube with integrated continuous high resolution airway imaging for patient airway control and lung isolation capability in the Netherlands.

19 Mar 2012

Prostate Center of Academic Urology receives accreditation from ACR, ASTRO

The Prostate Center of Academic Urology has been awarded a three-year term of accreditation in radiation oncology from the American College of Radiology (ACR) and The American Society for Radiation Oncology.

19 Mar 2012

Top-line data from Provectus' PH-10 Phase 2 trial on plaque psoriasis

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced top-line data for the company's randomized controlled trial (RCT) of PH-10 for mild-to-moderate plaque psoriasis.

19 Mar 2012

RBCC's new agreement with n3D could help develop stem-cell therapies

As global demand for innovative new stem-cell therapies grows by the day, Rainbow BioSciences' new agreement with n3D Biosciences could help to bring these therapies to market faster than ever before.

19 Mar 2012

High job strain decreases risk of mortality in white-collar women

Work defined by high job demand and also high control, a so-called 'active job', decreased the risk of mortality in white-collar women, the Finnish study published in BMJ Open found.

19 Mar 2012

Convergence initiates CNV1014802 Phase II study in trigeminal neuralgia

Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announced that the Phase II proof of concept study for CNV1014802 for the treatment of pain associated with trigeminal neuralgia (TN) has started.

19 Mar 2012

Different mechanisms might be involved in relapsing and progressive onset MS

Patients with relapsing onset Multiple Sclerosis (MS) who consumed alcohol, wine, coffee and fish on a regular basis took four to seven years longer to reach the point where they needed a walking aid than people who never consumed them. However the study, published in the April issue of the European Journal of Neurology, did not observe the same patterns in patients with progressive onset MS.

19 Mar 2012

New software tool can accurately estimate risk of heart disease

University of Granada researchers have developed a software tool that makes an accurate estimation of the risk that a person has to suffer a heart disease. In addition, this software tool allows the performance of massive risk estimations, i.e. it helps estimating the risk that a specific population group has of suffering a heart condition. The researchers employed a sample including 3 000 patients.

19 Mar 2012

EU-funded 'afresh'-project looks at food and physical activity

Food and physical activity are looked at together in the EU-funded "afresh"-project. Eight regional clusters - strong in food and/or health - currently are setting up their joint future agenda aiming at the prevention of diet-and activity related deseases like obesity, diabetes, cardiovasculaire deseases, osteoporose, etc.

19 Mar 2012

AARP announces nationwide launch of You've Earned a Say

'Today, at a town hall meeting in Pocatello, AARP state and national leaders are set to announce the launch of You've Earned a Say, a national conversation about strengthening health and retirement security.

19 Mar 2012

Air emissions near natural gas drilling sites may contribute to health problems

In a new study, researchers from the Colorado School of Public Health have shown that air pollution caused by hydraulic fracturing or fracking may contribute to acute and chronic health problems for those living near natural gas drilling sites.

19 Mar 2012

arGEN-X introduces NHance technology to create therapeutic antibodies

arGEN-X announces today the launch of NHance, its latest cutting-edge technology enabling the creation of truly differentiated human antibody therapeutics.

19 Mar 2012

AstraZeneca CEO to take part in panel discussion on Ethical Practices in the Pharmaceutical Sector

David Brennan, CEO of AstraZeneca, will take part in the plenary session panel discussion on "Ethical Practices in the Pharmaceutical Sector" at the EuroMeeting 2012 in Copenhagen on Monday 26 March.

19 Mar 2012

Exercise can induce sexual pleasure, female orgasm

Findings from a first-of-its-kind study by Indiana University researchers confirm anecdotal evidence that exercise -- absent sex or fantasies -- can lead to female orgasm.

19 Mar 2012

Molecular ticket determines RNA's destination and speed inside egg cell

Like any law-abiding train passenger, a molecule called oskar RNA carries a stamped ticket detailing its destination and form of transport, scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have found.

19 Mar 2012

Researchers show how errant form of LYP can disrupt the immune system

Autoimmune diseases, such as Type I diabetes and rheumatoid arthritis, are caused by an immune system gone haywire, where the body's defense system assaults and destroys healthy tissues. A mutant form of a protein called LYP has been implicated in multiple autoimmune diseases, but the precise molecular pathway involved has been unknown.

19 Mar 2012